Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells
US5861315A · kind A · utility
71Cited by
0References
8Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Oct 16, 1996 |
| Grant date | Jan 19, 1999 |
| Priority date | — |
| Expiry date | Oct 16, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/23
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Stem cell factor in combination with soluble interleukin-6 receptor, interleukin-6, for gp130 signaling, supports the proliferation, differentiation and terminal maturation of blood cells from normal human hematopoietic multipotential cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.